Portfolio company
MRM Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops microbiome-based live biotherapeutic products for patients with chronic inflammatory diseases and immune-oncology conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
KOBIOLABS
This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.
Microbiotica
This company develops live bacterial therapeutics and biomarkers for patients with inflammatory bowel disease and advanced melanoma.
EnteroBiotix
This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.
Human Biome
This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.
Metabogen
This company develops microbiome-based probiotics and pharmaceuticals for the probiotic and pharmaceutical industries to treat various health conditions.
Morphic Therapeutic
This biopharmaceutical company develops oral integrin therapies for patients with serious chronic diseases, including autoimmune conditions, fibrosis, and inflammatory bowel disease.
Kanvas Biosciences
This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.
